Australia markets closed

Elixinol Wellness Limited (ELLXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0194+0.0004 (+2.16%)
At close: 03:04PM EST

Elixinol Wellness Limited

680 George Street
Level 12
Sydney, NSW 2000
61 2 4044 4585

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Ronald Dufficy BEC, FCPAInterim Global Chief Exec. Officer229.97kN/AN/A
Ms. Josephine LorenzGlobal CFO & Group Financial ControllerN/AN/AN/A
Glen ZurcherAccount Director of Investor Relations DepartmentN/AN/AN/A
Ms. Teresa ClearyGen. Counsel & Company Sec.N/AN/AN/A
Mr. Rob HasselmanPres of AmericasN/AN/AN/A
Ms. Beata SilberGlobal Head of R&D and InnovationN/AN/AN/A
Ms. Kim Bradley-WareJoint Company Sec.N/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

Corporate governance

Elixinol Wellness Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.